GE Healthcare expands API facility in Lindesnes, Norway for $80M

GE Healthcare is investing $80 million to expand its active pharmaceutical ingredient manufacturing facility in Lindesnes, Norway, increasing contrast media production capacity by 30% and creating approximately 100 jobs. The expansion aims to add 30 million patient doses per year by 2025.

“GE Healthcare is investing $80m in the expansion of the facility.”pharmaceutical-technology.com

• 1 source
• pharmaceutical-technology.comGE Healthcare’s API Facility Expansion, Lindesnes, NorwaysamathareniguntaMay 19, 2023

Summarized from public sources; check the original articles before acting on it.